Skip to content
10-Q

Quarterly Report

Ernexa Therapeutics Inc. ERNA ERNAW

0001493152-25-011910

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 7.67M sh
Shares Diluted Q2 2025 · Jun 30, 2025 5.18M sh
Shares Diluted Q2 2025 · Jun 30, 2025 4.35M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 361K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 361K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$4.6M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$6.01M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $4.32M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $2.59M
Stockholders Equity Q2 2025 · Jun 30, 2025 $4.44M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$5.95M
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.7M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$8.53M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$3.41M
Stockholders Equity Q2 2025 · Dec 31, 2023 $2.23M
Current Liabilities Q2 2025 · Jun 30, 2025 $2.65M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.94M
Total Liabilities Q2 2025 · Jun 30, 2025 $3.14M
Total Liabilities Q2 2025 · Dec 31, 2024 $3.57M
Current Assets Q2 2025 · Jun 30, 2025 $4.79M
Current Assets Q2 2025 · Dec 31, 2024 $2.35M
Total Assets Q2 2025 · Jun 30, 2025 $7.58M
Total Assets Q2 2025 · Dec 31, 2024 $5.27M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.61
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.61
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$15.34
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$33.75
Eps Basic Q2 2025 · Jun 30, 2025 −$0.61
Eps Basic Q2 2025 · Jun 30, 2025 −$2.61
Eps Basic restated Q2 2025 · Jun 30, 2024 −$15.34
Eps Basic restated Q2 2025 · Jun 30, 2024 −$33.75
Net Income Q2 2025 · Jun 30, 2025 −$3.14M
Net Income Q2 2025 · Jun 30, 2025 −$11.34M
Net Income Q2 2025 · Jun 30, 2024 −$5.53M
Net Income Q2 2025 · Jun 30, 2024 −$12.18M
Operating Income Q2 2025 · Jun 30, 2025 −$2.5M
Operating Income Q2 2025 · Jun 30, 2025 −$5.23M
Operating Income Q2 2025 · Jun 30, 2024 −$4.93M
Operating Income Q2 2025 · Jun 30, 2024 −$10.72M
Capex Q2 2025 · Jun 30, 2024 $350K
Gross Profit Q2 2025 · Jun 30, 2024 −$48K
Gross Profit Q2 2025 · Jun 30, 2024 −$62K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $95K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $156K